Michael R. Cohen ScD, MS, RPH

June 2012 
Volume 42  Number 6
Pages 16 - 16
  PDF Version Available!

At least three medication errors associated with the inadvertent administration of the I.V. antineoplastic drug bortezomib into the intrathecal space have been reported in Europe since 2003. Although the FDA has received no such reports in North America, the same risk exists here.In all three reported cases, misadministration of bortezomib occurred when intrathecal chemotherapy or another intrathecal drug was scheduled on the same day and at the same time as I.V. bortezomib therapy. Intrathecal chemotherapy and I.V. bortezomib are both administered in small volumes via small syringes, creating a condition favorable to error. Health Canada and Janssen, Inc., the manufacturer of bortezomib, have issued an alert recommending that intrathecal therapies be scheduled at a different time than other parenteral chemotherapy. Don't rely on syringe labeling alone, as similar errors involving vinca alkaloids (such as vinCRIStine) have occurred despite proper syringe labeling.In some healthcare settings,

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

Featured Jobs

Benefits of Membership

FREE E-Newsletters
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues

Join our CESaver program to earn up to 100 contact hours for only $34.95
Register Now

Explore a world of online resources

Become a Member